Differential expression of Type I interferon and inflammatory genes in SARS-CoV-2-infected patients treated with monoclonal antibodies.


Journal

Immunity, inflammation and disease
ISSN: 2050-4527
Titre abrégé: Immun Inflamm Dis
Pays: England
ID NLM: 101635460

Informations de publication

Date de publication:
10 2023
Historique:
revised: 07 07 2023
received: 16 05 2023
accepted: 20 07 2023
medline: 1 11 2023
pubmed: 31 10 2023
entrez: 31 10 2023
Statut: ppublish

Résumé

Considering the reported efficacy of monoclonal antibodies (mAbs) directed against the Spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in reducing disease severity, the aim of this study was to investigate the innate immune response before and after mAbs treatment in 72 vaccinated and 31 unvaccinated SARS-CoV-2 patients. The mRNA levels of IFN-I, IFN-related genes and cytokines were evaluated using RT/real-time quantitative PCR. Vaccinated patients showed increased rate of negative SARS-CoV-2 PCR tests on nasopharyngeal swab compared with unvaccinated ones after mAbs treatment (p = .002). Unvaccinated patients had lower IFN-α/ω and higher IFN-related genes (IFNAR1, IFNAR2, IRF9, ISG15, ISG56 and IFI27) and cytokines (IL-6, IL-10 and TGF-β) mRNA levels compared to vaccinated individuals before mAbs (p < .05 for all genes). Increased IFN-α/ω, IFNAR1, IFNAR2 and IRF9 levels were observed in unvaccinated patients after mAbs treatment, while the mRNA expression ISGs and IL-10 were reduced in all patients. These data suggest that anti-S vaccinated patients have increased levels of innate immune genes compared to unvaccinated ones. Also, gene expression changes in IFN genes after mAbs administration are different according to the vaccination status of patients.

Identifiants

pubmed: 37904704
doi: 10.1002/iid3.968
pmc: PMC10571496
doi:

Substances chimiques

Interferon Type I 0
Antibodies, Monoclonal 0
Interleukin-10 130068-27-8
Interferon-alpha 0
Cytokines 0
RNA, Messenger 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e968

Informations de copyright

© 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.

Références

Med Lett Drugs Ther. 2020 Dec 28;62(1614):201-202
pubmed: 33451174
Mamm Genome. 2018 Aug;29(7-8):593-602
pubmed: 29982912
Viral Immunol. 2021 Dec;34(10):679-688
pubmed: 34882013
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Nat Commun. 2021 Mar 12;12(1):1618
pubmed: 33712622
Front Immunol. 2022 Sep 02;13:975363
pubmed: 36119092
Nat Immunol. 2022 Apr;23(4):543-555
pubmed: 35288714
N Engl J Med. 2021 Jan 21;384(3):238-251
pubmed: 33332778
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Vaccines (Basel). 2022 Apr 12;10(4):
pubmed: 35455340
Clin Infect Dis. 2023 Feb 8;76(3):e148-e154
pubmed: 35870128
J Interferon Cytokine Res. 2022 Aug;42(8):352-368
pubmed: 35647937
Nat Commun. 2021 Mar 30;12(1):1961
pubmed: 33785765
Trends Mol Med. 2022 Jun;28(6):497-512
pubmed: 35466062
Blood. 2014 Jul 10;124(2):188-95
pubmed: 24876563
Cell Rep. 2021 Aug 10;36(6):109504
pubmed: 34352226
Am J Respir Cell Mol Biol. 2016 Dec;55(6):759-766
pubmed: 27603223
J Med Virol. 2022 Jan;94(1):63-81
pubmed: 34468995
Nat Immunol. 2009 Jan;10(1):116-125
pubmed: 19029902
Eur J Immunol. 2022 Jul;52(7):1120-1128
pubmed: 35419822
Cytokine. 2021 Jul;143:155507
pubmed: 33839002
J Osteopath Med. 2022 Sep 20;122(12):635-640
pubmed: 36123325
Emerg Microbes Infect. 2020 Dec;9(1):1123-1130
pubmed: 32475230
Viruses. 2022 Jun 27;14(7):
pubmed: 35891380
Virology. 2011 Mar 15;411(2):206-15
pubmed: 21216425
Biomolecules. 2021 Jul 06;11(7):
pubmed: 34356617
Med Lett Drugs Ther. 2021 Apr 5;63(1621):49-50
pubmed: 33830966
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Nat Rev Immunol. 2021 Aug;21(8):475-484
pubmed: 34211186
Front Immunol. 2021 Apr 12;12:633769
pubmed: 33912161
Cell Rep. 2021 May 18;35(7):109126
pubmed: 33974846

Auteurs

Luca Maddaloni (L)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Letizia Santinelli (L)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Ginevra Bugani (G)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Elio G Cacciola (EG)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Alessandro Lazzaro (A)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Chiara M Lofaro (CM)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Sara Caiazzo (S)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Federica Frasca (F)

Virology Laboratory, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Matteo Fracella (M)

Virology Laboratory, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Camilla Ajassa (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Cristiana Leanza (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Anna Napoli (A)

Laboratory of Microbiology and Virology, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Lilia Cinti (L)

Laboratory of Microbiology and Virology, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Aurelia Gaeta (A)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Guido Antonelli (G)

Virology Laboratory, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Giancarlo Ceccarelli (G)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome, Italy.

Claudio M Mastroianni (CM)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Carolina Scagnolari (C)

Virology Laboratory, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Gabriella d'Ettorre (G)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH